Asia Pacific Laboratory Robotics Market Size, Share & Trends Analysis Report By End Use (Clinical Laboratory and Research Laboratory), By Application, By Product, By Country and Growth Forecast, 2024 - 2031

The Asia Pacific Laboratory Robotics Market is projected to witness market growth of 7.5% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Laboratory Robotics Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $177.6 million by 2031. The Japan market is capturing a CAGR of 7% during (2024 - 2031). Additionally, The India market would register a CAGR of 8.4% during (2024 - 2031).



In industrial laboratories, robots perform automated inspections, sample testing, and product validation. This ensures product quality, compliance with regulatory standards, and consistency in manufacturing processes. Automated systems analyze water, air, and soil samples for contaminants, pollutants, and microbial pathogens. This supports environmental monitoring, regulatory compliance, and public health assessments.

The adoption of laboratory robotics has been steadily increasing across various industries and scientific disciplines, driven by technological advancements, efficiency gains, and the need for high precision and throughput. Laboratory robotics have evolved significantly, integrating advanced technologies such as AI, machine learning, and robotic vision systems. These advancements enhance robotic capabilities in handling complex tasks, adapting to variable conditions, and improving overall system performance. Robotic platforms offer greater flexibility, scalability, and integration with other laboratory instruments and systems, making them more attractive for adoption in diverse applications.

China’s pharmaceutical sector increasingly adopts laboratory robotics for automated drug discovery processes, including high-throughput screening (HTS) and compound management. Robotics enable pharmaceutical companies to efficiently handle large-scale screening of drug candidates, accelerating the discovery of new therapies while reducing labour costs and improving accuracy. According to the International Trade Administration (ITA), China’s pharmaceutical sector has constantly grown and reached $161.8 billion in 2023, taking about 30% of the global industry share. Laboratory robotics are crucial in biomanufacturing facilities across China, automating cell culture, fermentation, and purification processes. Robotics ensure consistent product quality, scalability, and operational efficiency in biopharmaceutical production, meeting the growing demand for innovative therapies and biologics.

The adoption of laboratory robotics in China supports advancements in precision medicine and personalized healthcare solutions. Robotics enable precise handling of biological samples, genomic sequencing, and biomarker analysis, facilitating tailored treatment approaches and enhancing patient outcomes through targeted therapies. The burgeoning biotechnology sector and expanding regional pharmaceutical industry are key drivers propelling market growth.

List of Key Companies Profiled

• Peak Analysis and Automation Ltd (PAA)
• PerkinElmer, Inc.
• Thermo Fisher Scientific Inc.
• Hudson Robotics, Inc.
• Anton Paar GmbH
• Danaher Corporation (Beckman Coulter, Inc.)
• Siemens Healthineers AG (Siemens AG)
• AB Controls, Inc.
• Abbott Laboratories

Market Report Segmentation

By End Use

• Clinical Laboratory
• Research Laboratory

By Application

• Drug Discovery
• Genomics Solutions
• Clinical Diagnosis
• Proteomics Solutions
• Microbiology Solutions

By Product

• Lab Automation Workstations
• Automated Plate Handlers
• Automated Liquid Handling Robots
• Robotic Arms
• Microplate Readers and Washers
• Others

By Country

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific